Loading...

MetaVia Inc.

MTVANASDAQ
Healthcare
Biotechnology
$1.88
$0.77(69.37%)
U.S. Market opens in NaNh NaNm

MetaVia Inc. Fundamental Analysis

MetaVia Inc. (MTVA) shows weak financial fundamentals with a PE ratio of -0.68, profit margin of 0.00%, and ROE of -1.73%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position150.30%
PEG Ratio-0.00
Current Ratio2.73

Areas of Concern

ROE-1.73%
Operating Margin0.00%
We analyze MTVA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -147.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-147.8/100

We analyze MTVA's fundamental strength across five key dimensions:

Efficiency Score

Weak

MTVA struggles to generate sufficient returns from assets.

ROA > 10%
-91.22%

Valuation Score

Excellent

MTVA trades at attractive valuation levels.

PE < 25
-0.68
PEG Ratio < 2
-0.00

Growth Score

Weak

MTVA faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-9.76%

Financial Health Score

Excellent

MTVA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
2.73

Profitability Score

Weak

MTVA struggles to sustain strong margins.

ROE > 15%
-172.92%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is MTVA Expensive or Cheap?

P/E Ratio

MTVA trades at -0.68 times earnings. This suggests potential undervaluation.

-0.68

PEG Ratio

When adjusting for growth, MTVA's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values MetaVia Inc. at 0.99 times its book value. This may indicate undervaluation.

0.99

EV/EBITDA

Enterprise value stands at -1.30 times EBITDA. This is generally considered low.

-1.30

How Well Does MTVA Make Money?

Net Profit Margin

For every $100 in sales, MetaVia Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-1.73 in profit for every $100 of shareholder equity.

-1.73%

ROA

MetaVia Inc. generates $-91.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-91.22%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-3.12 in free cash annually.

$-3.12

FCF Yield

MTVA converts -3.66% of its market value into free cash.

-3.66%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.68

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.73

vs 25 benchmark

ROA

Return on assets percentage

-0.91

vs 25 benchmark

ROCE

Return on capital employed

-1.51

vs 25 benchmark

How MTVA Stacks Against Its Sector Peers

MetricMTVA ValueSector AveragePerformance
P/E Ratio-0.6828.65 Better (Cheaper)
ROE-172.92%795.00% Weak
Net Margin0.00%-49787.00% (disorted) Weak
Debt/Equity0.020.40 Strong (Low Leverage)
Current Ratio2.733.73 Strong Liquidity
ROA-91.22%-20255.00% (disorted) Weak

MTVA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MetaVia Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

99.64%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

99.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ